Evidence map›Paper›PMID 41559736›Full record

ArticleTrials2026

The effectiveness and acceptability of face-to-face rehabilitation for patients with Long Covid who were not hospitalised with their acute infection: a mixed-methods study comprising a randomised controlled trial (RCT) with embedded qualitative component.

Kate Kontou, Enya Daynes, Sally J Singh, Rachael A Evans, Nikki Gardiner, Emma Chaplin, Matthew Richardson, Nicolette Bishop, Jennifer Creese, Nicola Bateman and 3 more

Abstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kate KontouCERS, Respiratory BRC, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK. kvk7@leicester.ac.uk.ORCID http://orcid.org/0000-0003-0367-1443
Enya DaynesCERS, Respiratory BRC, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
Sally J SinghCERS, Respiratory BRC, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
Rachael A EvansCERS, Respiratory BRC, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
Nikki GardinerGlenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
Emma ChaplinGlenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
Matthew RichardsonRespiratory Sciences, Glenfield Hospital, University of Leicester, Leicester, UK.
Nicolette BishopLoughborough University, Epinal Way, Loughborough, UK.
Jennifer CreeseDepartment of Population Health Sciences, George Davis Centre, University of Leicester, 15 Lancaster Road, Leicester, UK.
Nicola BatemanSchool of Business, University of Leicester, Brookfield, 266 London Road, Leicester, UK.
Adam WrightRespiratory Sciences, Glenfield Hospital, University of Leicester, Leicester, UK.
Elga ZivtinsPatient Advisory Group, Leicester, UK.
Linzy Houchen-WolloffCERS, Respiratory BRC, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.

Funding

Wellcome TrustWellcome Trust 223512/Z/21/Z
6 · The paper itself

Abstract

backgroundLong Covid is a term used to describe a multisystem condition that presents with a myriad of physical and psychological symptoms that continue or develop after acute COVID-19. Long Covid is a significant public health problem because of the nature of the illness, its negative impfact on everyday functioning, and the healthcare inequalities evident in access and experience, notably in terms of ethnicity and socioeconomic status. Evidence in patients hospitalised with their acute infection suggests exercise-based rehabilitation could be helpful to improve exercise tolerance, respiratory symptoms, fatigue, and cognition; however, research is needed to determine whether exercise-based rehabilitation is effective and acceptable for patients with Long Covid who were not hospitalised.

methodsThis mixed-methods study comprises a single-centre, randomised controlled trial to determine whether face-to-face rehabilitation increases exercise capacity compared to usual care alone in non-hospitalised patients with Long Covid, with embedded qualitative components to explore intervention acceptability in the context of healthcare inequalities. Usual care is as defined by the National Institute for Clinical Excellence (NICE) Covid-19 guidance. The rehabilitation intervention will take place twice a week for 6 weeks and will combine symptom-titrated exercise with self-management education. The proposed sample size of 56 for the randomised controlled trial is calculated on the primary outcome of Incremental Shuttle Walking Test (ISWT) distance, with a change of 50metres (m) at 90% power, a standard deviation of 17 m, and a 0.05 type 1 error. DISCUSSION: A mixed-methods approach has been chosen as quantitative data alone would be insufficient to answer the research question, and mixing the data will enable a more comprehensive understanding and ensure there is an equal focus on outcomes and experiences of a face-to-face exercise-based rehabilitation programme. A healthcare inequalities lens will explore who may be under-represented, with the qualitative work providing further evidence as to why this may be the case. It is recognised that meeting recruitment targets in the context of reducing referral rates and funding for Long Covid services may prove challenging.

trial registrationISRCTN trial registry (ISRCTN33340595). Registered on 30 September 2024.

Indexed as

COVID-19Exercise TherapyPatient Acceptance of Health CareExercise ToleranceHumansPost-Acute COVID-19 SyndromeQualitative ResearchRandomized Controlled Trials as TopicSARS-CoV-2Treatment OutcomeLong CovidMixed methodsRandomised controlled trialRehabilitation

Identifiers

PMID41559736
PMCPMC12905934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.